We are live on ! Find out more
LOAMS

Lombard Odier Asset Management (Switzerland) Portfolio holdings

AUM $2.63B
1-Year Est. Return 31.52%
This Fund
S&P 500
This Quarter Est. Return
-2.06%
1 Year Est. Return
+31.52%
3 Year Est. Return
+98.77%
5 Year Est. Return
+107.98%
10 Year Est. Return
+494.97%
AUM
$1.18B
AUM Growth
-$2.33M
Cap. Flow
+$4.29M
Cap. Flow %
0.36%
Top 10 Hldgs %
24.05%
Holding
357
New
34
Increased
28
Reduced
196
Closed
83

Sector Composition

Rank Sector Weight
1 Healthcare 41.98%
2 Financials 15.26%
3 Consumer Discretionary 12.3%
4 Technology 7.74%
5 Industrials 4.24%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CIXX
1
DELISTED
CI Financial Corp.
CIXX
$36.3M 3.08%
2,000,000
IWD icon
2
iShares Russell 1000 Value ETF
IWD
$84.1B
$35.8M 3.03%
+263,100
New +$39.5M
MFC icon
3
Manulife Financial
MFC
$73.2B
$35.7M 3.03%
1,200,000
+195,730
+19% +$3.43M
IWO icon
4
iShares Russell 2000 Growth ETF
IWO
$14.9B
$33.7M 2.86%
+163,200
New +$36.7M
EFV icon
5
iShares MSCI EAFE Value ETF
EFV
$30B
$29.3M 2.48%
+759,800
New +$32.4M
TMO icon
6
Thermo Fisher Scientific
TMO
$222B
$23.9M 2.03%
47,091
-5,904
-11% -$3.3M
CVS icon
7
CVS Health
CVS
$119B
$23.2M 1.97%
243,288
-51,881
-18% -$5.14M
SCI icon
8
Service Corp International
SCI
$11.4B
$23.1M 1.96%
400,000
AMP icon
9
Ameriprise Financial
AMP
$49.9B
$21.4M 1.82%
85,000
-5,448
-6% -$1.43M
NBIX icon
10
Neurocrine Biosciences
NBIX
$16.6B
$21.1M 1.79%
199,092
-15,838
-7% -$1.61M
IQV icon
11
IQVIA
IQV
$40.2B
$20.8M 1.77%
115,000
-7,124
-6% -$1.56M
BMY icon
12
Bristol-Myers Squibb
BMY
$130B
$20.5M 1.74%
288,394
-5,237
-2% -$380K
DXCM icon
13
DexCom
DXCM
$33.5B
$20.1M 1.71%
249,848
-13,016
-5% -$1.1M
BC icon
14
Brunswick
BC
$5.27B
$19.6M 1.67%
300,000
+25,000
+9% +$1.88M
THO icon
15
Thor Industries
THO
$4.2B
$19.2M 1.63%
275,000
BMRN icon
16
BioMarin Pharmaceuticals
BMRN
$13.4B
$18.9M 1.6%
222,938
-27,579
-11% -$2.46M
PFE icon
17
Pfizer
PFE
$151B
$18.9M 1.6%
430,898
+396,891
+1,167% +$19.3M
SCHW
18
Charles Schwab
SCHW
$187B
$18.3M 1.55%
254,021
-4,317
-2% -$300K
UNH icon
19
UnitedHealth
UNH
$367B
$18M 1.53%
35,683
-7,748
-18% -$4.07M
HOLX
20
DELISTED
Hologic
HOLX
$17.7M 1.5%
275,000
-27,309
-9% -$1.89M
INCY icon
21
Incyte
INCY
$24.6B
$17.7M 1.5%
266,073
-7,748
-3% -$572K
ABBV icon
22
AbbVie
ABBV
$439B
$17.4M 1.48%
129,728
-5,758
-4% -$826K
LOW icon
23
Lowe's Companies
LOW
$124B
$17.3M 1.47%
92,254
-13,226
-13% -$2.58M
AAPL icon
24
Apple
AAPL
$4.47T
$17.3M 1.47%
125,234
+2,200
+2% +$345K
AXP icon
25
American Express
AXP
$231B
$16.5M 1.4%
122,175
+9,003
+8% +$1.36M

Similar funds

Lombard Odier Asset Management (Switzerland)'s Q3 2022 Portfolio in Review

As of Q3 2022, Lombard Odier Asset Management (Switzerland) held 357 positions worth $1.18B, down 0.2% from $1.18B the previous quarter. Its ten largest holdings account for 24% of the portfolio.

Lombard Odier Asset Management (Switzerland)'s Q3 2022 filing shows 34 new, 28 increased, 196 reduced and 83 closed positions. Its largest new stake was iShares Russell 1000 Value ETF: 263,100 shares worth $35.8M. The largest sale was Visa, an estimated $16.6M.

By sector, the portfolio is most concentrated in Healthcare at 42% of assets, down from 47% a quarter earlier, followed by Financials and Consumer Discretionary.

  • Lombard Odier Asset Management (Switzerland)'s largest Q3 2022 buy was iShares Russell 1000 Value ETF: 263,100 shares worth $35.8M.
  • Lombard Odier Asset Management (Switzerland) added most to Pfizer in Q3 2022, an estimated $19.3M increase.
  • Lombard Odier Asset Management (Switzerland)'s biggest Q3 2022 reduction was Visa, cutting an estimated $16.6M.
  • Lombard Odier Asset Management (Switzerland) fully exited Signature Bank in Q3 2022, selling an estimated $2.18M.
  • Lombard Odier Asset Management (Switzerland)'s ten largest holdings make up 24% of its $1.18B portfolio in Q3 2022.
  • Lombard Odier Asset Management (Switzerland) opened 34 new positions and closed 83 in Q3 2022.
  • Lombard Odier Asset Management (Switzerland)'s portfolio value fell 0.2% quarter-over-quarter to $1.18B.

Based on Lombard Odier Asset Management (Switzerland)'s 13F filing for Q3 2022, filed 14 Nov 2022.